Inogen Announces CFO Transition Plan

Author's Avatar
Dec 13, 2021

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mike Sergesketter as Interim Chief Financial Officer, effective immediately. Mr. Sergesketter most recently served as CFO of Kimball Electronics, Inc. where he was instrumental in helping to develop and execute the company’s globalization strategy while also building a robust finance function designed to support the company’s growth. He succeeds Alison Bauerlein who will be staying with the Company in a transitional finance role through the first quarter of 2022. The Company has retained a leading executive search firm to help with the search for a permanent replacement.